Deletion of src family kinase Lyn aggravates endotoxin-induced lung inflammation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 11, 2015, Pages L1376-L1381

  Gao, Rong ^a,b   Ma, Zhongsen ^a   Ma, Mengshi ^a,b   Yu, Jinyan ^a,b   Chen, Jiao ^b   Li, Zhenyu ^c   Shetty, Sreerama ^d   Fu, Jian ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Inlammasome; Inlammation; Kinase; Lung; Lyn

Indexed keywords

ENDOTOXIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN KINASE LYN; VASCULAR ENDOTHELIAL CADHERIN; AUTACOID; CADHERIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; LYN PROTEIN-TYROSINE KINASE; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVATION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; DEFICIENCY; ENZYMOLOGY; GENE DELETION; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD; CADHERINS; CASPASE 1; GENE DELETION; INFLAMMASOMES; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LUNG; MATRIX METALLOPROTEINASE 9; MICE, KNOCKOUT; NF-KAPPA B; PNEUMONIA; SRC-FAMILY KINASES;

EID: 84949497928     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00219.2015     Document Type: Article

References (44)

1. Abdel Fattah E, Bhattacharya A, Herron A, Safdar Z, Eissa NT. Critical role for IL-18 in spontaneous lung inlammation caused by autophagy deficiency. J Immunol 194: 5407-5416, 2015.
2. Brixey AG, Light RW. Pleural effusions due to dasatinib. Curr Opin Pulm Med 16: 351-356, 2010.
3. Chen R, Chen B. The role of dasatinib in the management of chronic myeloid leukemia. Drug Des Devel Ther 9: 773-779, 2015.
4. Chu CL, Lowell CA. The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation. J Immunol 175: 2880-2889, 2005.
5. Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Freden-burgh L, Massaro AF, Rogers A, Gazourian L, Nakahira K, Haspel JA, Landazury R, Eppanapally S, Christie JD, Meyer NJ, Ware LB, Christiani DC, Ryter SW, Baron RM, Choi AM. Inlammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 185: 1225-1234, 2012.
6. Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z. Matrix metalloproteinase-2 and-9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One 6: e20599, 2011.
7. Flemming S, Burkard N, Renschler M, Vielmuth F, Meir M, Schick MA, Wunder C, Germer CT, Spindler V, Waschke J, Schlegel N. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc Res 107: 32-44, 2015.
8. Fukumoto J, Fukumoto I, Parthasarathy PT, Cox R, Huynh B, Ramanathan GK, Venugopal RB, Allen-Gipson DS, Lockey RF, Kol-liputi N. NLRP3 deletion protects from hyperoxia-induced acute lung injury. Am J Physiol Cell Physiol 305: C182-C189, 2013.
9. Gao R, Ma Z, Hu Y, Chen J, Shetty S, Fu J. Sirt1 restrains lung inlammasome activation in a murine model of sepsis. Am J Physiol Lung Cell Mol Physiol 308: L847-L853, 2015.
10. Grailer JJ, Canning BA, Kalbitz M, Haggadone MD, Dhond RM, Andjelkovic AV, Zetoune FS, Ward PA. Critical role for the NLRP3 inlammasome during acute lung injury. J Immunol 192: 5974-5983, 2014.
11. Gray P, Dagvadorj J, Michelsen KS, Brikos C, Rentsendorj A, Town T, Crother TR, Arditi M. Myeloid differentiation factor-2 interacts with Lyn kinase and is tyrosine phosphorylated following lipopolysaccharide-induced activation of the TLR4 signaling pathway. J Immunol 187: 4331-4337, 2011.
12. Guo H, Callaway JB, Ting JP. Inlammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21: 677-687, 2015.
13. Han J, Zhang G, Welch EJ, Liang Y, Fu J, Vogel SM, Lowell CA, Du X, Cheresh DA, Malik AB, Li Z. A critical role for Lyn kinase in strengthening endothelial integrity and barrier function. Blood 122: 4140-4149, 2013.
14. Hara H, Tsuchiya K, Kawamura I, Fang R, Hernandez-Cuellar E, Shen Y, Mizuguchi J, Schweighoffer E, Tybulewicz V, Mitsuyama M. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inlammasome activity. Nat Immunol 14: 1247-1255, 2013.
15. Hong H, Kitaura J, Xiao W, Horejsi V, Ra C, Lowell CA, Kawakami Y, Kawakami T. The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 110: 2511-2519, 2007.
16. Hong JH, Lee SE, Choi SY, Kim SH, Jang EJ, Bang JH, Park JE, Jeon HR, Oh YJ, Yi JE, Jung HO, Youn HJ, Kim DW. Reversible pulmonary arterial hypertension associated with dasatinib for chronic myeloid leukemia. Cancer Res Treat 47: 937-942, 2014.
17. Hong JJ, Yankee TM, Harrison ML, Geahlen RL. Regulation of signaling in Б cells through the phosphorylation of Syk on linker region tyrosines. A mechanism for negative signaling by the Lyn tyrosine kinase. J Biol Chem 277: 31703-31714, 2002.
18. Hu G, Place AT, Minshall RD. Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules. Chem Biol Interact 171: 177-189, 2008.
19. Imanifooladi AA, Yazdani S, Nourani MR. The role of nuclear fac-tor-кБ in inflammatory lung disease. Inflamm Allergy Drug Targets 9: 197-205, 2010.
20. Kolliputi N, Galam L, Parthasarathy PT, Tipparaju SM, Lockey RF. NALP-3 inlammasome silencing attenuates ceramide-induced transepi-thelial permeability. J Cell Physiol 227: 3310-3316, 2012.
21. Lechtenberg BC, Mace PD, Riedl SJ. Structural mechanisms in NLR inflammasome signaling. Curr Opin Struct Biol 29: 17-25, 2014.
22. Liu SF, Malik AB. NF-кБ activation as a pathological mechanism of septic shock and inlammation. Am J Physiol Lung Cell Mol Physiol 290: L622-L645, 2006.
23. Liu YY, Li LF, Fu JY, Kao KC, Huang CC, Chien Y, Liao YW, Chiou SH, Chang YL. Induced pluripotent stem cell therapy ameliorates hyper-oxia-augmented ventilator-induced lung injury through suppressing the Src pathway. PLoS One 9: e109953, 2014.
24. Luo YP, Jiang L, Kang K, Fei DS, Meng XL, Nan CC, Pan SH, Zhao MR, Zhao MY. Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1. Int Immu-nopharmacol 20: 24-32, 2014.
25. Magnani M, Crinelli R, Bianchi M, Antonelli A. The ubiquitin-depen-dent proteolytic system and other potential targets for the modulation of nuclear factor-кБ (NF-кБ). Curr Drug Targets 1: 387-399, 2000.
26. Man SM, Kanneganti TD. Regulation of inlammasome activation. Immunol Rev 265: 6-21, 2015.
27. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D, Saftig P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and ß-catenin translocation. Proc Natl Acad Sci USA 102: 9182-9187, 2005.
28. Palenski TL, Sorenson CM, Sheibani N. Inflammatory cytokine-specific alterations in retinal endothelial cell function. Microvasc Res 89: 57-69, 2013.
29. Salomao R, Brunialti MK, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M. Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 38: 227-242, 2012.
30. Salomao R, Martins PS, Brunialti MK, Fernandes Mda L, Martos LS, Mendes ME, Gomes NE, Rigato O. TLR signaling pathway in patients with sepsis. Shock 30, Suppl 1: 73-77, 2008.
31. Scapini P, Pereira S, Zhang H, Lowell CA. Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol Rev 228: 23-40, 2009.
32. Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol 279: L419-L422, 2000.
33. Sukriti S, Tauseef M, Yazbeck P, Mehta D. Mechanisms regulating endothelial permeability. Pulm Circ 4: 535-551, 2014.
34. Taxman DJ, Holley-Guthrie EA, Huang MT, Moore CB, Bergstralh DT, Allen IC, Lei Y, Gris D, Ting JP. The NLR adaptor ASC/PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inlammasome. J Biol Chem 286: 19605-19616, 2011.
35. Tsantikos E, Maxwell MJ, Kountouri N, Harder KW, Tarlinton DM, Hibbs ML. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development. J Immunol 189: 1726-1736, 2012.
36. Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP, Mackman N. Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood 118: 2366-2374, 2011.
37. Wu Z, Liu MC, Liang M, Fu J. Sirt1 protects against thrombomodulin down-regulation and lung coagulation after particulate matter exposure. Blood 119: 2422-2429, 2012.
38. Xiao W, Nishimoto H, Hong H, Kitaura J, Nunomura S, Maeda-Yamamoto M, Kawakami Y, Lowell CA, Ra C, Kawakami T. Positive and negative regulation of mast cell activation by Lyn via the FceRI. J Immunol 175: 6885-6892, 2005.
39. Xu P, Wen Z, Shi X, Li Y, Fan L, Xiang M, Li A, Scott MJ, Xiao G, Li S, Billiar TR, Wilson MA, Fan J. Hemorrhagic shock augments Nlrp3 inlammasome activation in the lung through impaired pyrin induction. J Immunol 190: 5247-5255, 2013.
40. Xu Y, Harder KW, Huntington ND, Hibbs ML, Tarlinton DM. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22: 9-18, 2005.
41. Yamanashi Y, Fukui Y, Wongsasant B, Kinoshita Y, Ichimori Y, Toyoshima K, Yamamoto T. Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon Б-cell antigen receptor-mediated signaling. Proc Natl Acad Sci USA 89: 1118-1122, 1992.
42. Yuan SY, Shen Q, Rigor RR, Wu MH. Neutrophil transmigration, focal adhesion kinase and endothelial barrier function. Microvasc Res 83: 82-88, 2012.
43. Yun S, Anwer F, Vincelette ND. Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia. BMJ Case Rep 2014: 2014.
44. Zhao J, Zhang H, Huang Y, Wang H, Wang S, Zhao C, Liang Y, Yang N. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-_B activation. Int Immunopharmacol 17: 116-122, 2013.